Target intelligence / Profile preview

NF-kappa-B inhibitor alpha (IκBα) (IκBα)

Target
IκBα
Molecular classification
Other
01

Overview

NF-kappa-B inhibitor alpha (IκBα) is a key regulatory protein that controls the activity of the NF-kappa-B transcription factor, a central mediator of inflammation and immune responses [1, 11]. In unstimulated cells, IκBα binds to NF-kappa-B dimers in the cytoplasm, masking their nuclear localization signals and preventing their translocation to the nucleus [1, 2]. Upon cellular stimulation by cytokines or pathogens, IκBα is phosphorylated by the IκB kinase (IKK) complex, which triggers its ubiquitination and subsequent degradation by the 26S proteasome [11, 15]. The loss of IκBα allows NF-kappa-B to enter the nucleus and initiate the transcription of various pro-survival and pro-inflammatory genes [11]. Dysregulation of this process, through mutations or excessive degradation of IκBα, is linked to chronic inflammatory diseases, autoimmune disorders, and various cancers, including Hodgkin's lymphoma and leukemia [1, 5, 8]. Therapeutic strategies involving this target focus on preventing IκBα degradation using proteasome inhibitors or IKK inhibitors to maintain NF-kappa-B in an inactive state [3, 4, 10]. Additionally, experimental therapies utilize "super-repressor" versions of IκBα that are resistant to degradation to achieve more targeted pathway inhibition [16, 17].

Other names
IKBAMAD-3NFKBINFKBIANuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alphaMajor histocompatibility complex enhancer-binding protein MAD3Ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant 2 (EDAID2)
02

Mechanism of action

Drugs typically modulate this target by preventing its phosphorylation via IKK inhibition or its degradation via proteasome inhibition, which stabilizes the IκBα/NF-kappa-B complex in the cytoplasm. This stabilization prevents nuclear translocation of NF-kappa-B and subsequent transcription of pro-inflammatory and anti-apoptotic genes. Experimental approaches also include the direct delivery of degradation-resistant "super-repressor" variants of the protein.

03

Biological functions

Signal transductionImmune responseApoptosisCell proliferationCell deathTranscription regulation
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Widespread immunosuppressionIncreased risk of opportunistic infectionsSusceptibility to apoptosis in healthy tissuesPotential on-target toxicities (e.g., hepatotoxicity or gastrointestinal toxicity)
06

Interacting drugs

Bortezomib

7 more in the full profile.

07

Biomarkers

Phospho-IκBα (Ser32/36)Total IκBα protein levelsNF-kappa-B p65 nuclear translocationCirculating IL-6 levelsCirculating TNF-alpha levels

Beyond the preview

Go deeper on NF-kappa-B inhibitor alpha (IκBα) (IκBα).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NF-kappa-B inhibitor alpha (IκBα) (IκBα).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call